Co-infected cells express both KSHV and EBV genes <i>in vitro</i> necessary for their survival and growth. by Mitchell Hayes (5334887)

Mutations in <i>rbm-26</i> cause axon degeneration and axon overlap defects. by Tamjid A. Chowdhury (14149846)

Overall cardiovascular disease 2^nd level risk factors rank ordered by attributed DALYs in 1990 and 2021 for females (above) and males (below) in Chile. Red. by Camilo Briones-Valdivieso (21567535)

Subjects:

Cardiovascular diseases ranked by DALYs in 1990 and 2021 for females (above) and males (below) in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Overall CVD disease burden in DALYs attributable to 1^st-level risk factors in Chile. DALYs rates are expressed per 100,000 individuals, with a 95% uncertainty interval. by Camilo Briones-Valdivieso (21567535)

Subjects:

Overall cardiovascular disease DALYs age-standardised rate over time 1990-2021 in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Percentage distribution of DALYs for cardiovascular diseases in 2021 in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Cat Stress Score (CSS) was significantly predicted by intake type and days in the study. by Allison Andrukonis (11846404)

Significant associations in the candidate gene approach. by Dai Nogimura (21445649)

Subjects:

Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

“…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P_i‐induced VSMCs. …”

Decomposition analysis of the changes in the number of deaths from hypertension-attributable AA in different SDI regions from 1990 to 2021. by Guanghui Yu (423945)

Subjects:

Deaths and ASMR of AA^a due to Hypertension in 1990 and 2021, along with the EAPC from 1990 to 2021. by Guanghui Yu (423945)

Subjects:

Decomposition analysis of the changes in AA deaths attributed to hypertension across diverse SDI regions from 1990 to 2021. by Guanghui Yu (423945)

Subjects:

In 2021, ASDR of AA caused by hypertension in 204 countries and regions classified by the SDI. by Guanghui Yu (423945)

Subjects:

The disease burden of AA caused by hypertension in 204 countries and regions. by Guanghui Yu (423945)

Subjects:

The relationship between age-standardized DALYs due to hypertension-induced AA and the SDI. by Guanghui Yu (423945)

Subjects:

Frontier Analysis Based on ASDR and SDI. by Guanghui Yu (423945)

Subjects:

The EAPC in AA caused by hypertension in 204 countries and regions from 1990 to 2021. by Guanghui Yu (423945)

Subjects:

DALYs and ASDR for AA due to hypertension in 1990 and 2021, along with the EAPC from 1990 to 2021. by Guanghui Yu (423945)

Subjects:

The ASDR of AA caused by hypertension in 204 countries and regions in 2021. by Guanghui Yu (423945)

Subjects: